Cargando…

The Effect of 10 Most Common Nonurological Primary Cancers on Survival in Men With Secondary Prostate Cancer

BACKGROUND: This study aims to test the effect of the 10 most common nonurological primary cancers (skin, rectal, colon, lymphoma, leukemia, pancreas, stomach, esophagus, liver, lung) on overall mortality (OM) after secondary prostate cancer (PCa). MATERIAL AND METHODS: Within the Surveillance, Epid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wenzel, Mike, Nocera, Luigi, Würnschimmel, Christoph, Collà Ruvolo, Claudia, Tian, Zhe, Saad, Fred, Briganti, Alberto, Tilki, Derya, Graefen, Markus, Becker, Andreas, Roos, Frederik C., Chun, Felix K. H., Karakiewicz, Pierre I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526938/ https://www.ncbi.nlm.nih.gov/pubmed/34692543 http://dx.doi.org/10.3389/fonc.2021.754996

Ejemplares similares

Survival advantage of Asian metastatic prostate cancer patients treated with external beam radiotherapy over other races/ethnicities
por: Würnschimmel, Christoph, et al.
Publicado: (2021)

Race/Ethnicity may be an Important Predictor of Life Expectancy in Localized Prostate Cancer Patients: Novel Analyses Using Social Security Administration Life Tables
por: Würnschimmel, Christoph, et al.
Publicado: (2022)

Incidence rates and contemporary trends in primary urethral cancer
por: Wenzel, Mike, et al.
Publicado: (2021)

Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
por: Wenzel, Mike, et al.
Publicado: (2021)

Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
por: Wenzel, Mike, et al.
Publicado: (2023)

Epidemiology of Unconventional Histological Subtypes of Urethral Cancer
por: Wenzel, Mike, et al.
Publicado: (2023)

Temporal trends, tumor characteristics and stage-specific survival in penile non-squamous cell carcinoma vs. squamous cell carcinoma
por: Wenzel, Mike, et al.
Publicado: (2021)

The effect of race/ethnicity on cancer-specific mortality after salvage radical prostatectomy
por: Wenzel, Mike, et al.
Publicado: (2022)

Differences between rural and urban prostate cancer patients
por: Stolzenbach, Lara Franziska, et al.
Publicado: (2020)

Bladder cancer stage and mortality: urban vs. rural residency
por: Deuker, Marina, et al.
Publicado: (2020)

Predicting the probability of pT3 or higher pathological stage at radical prostatectomy: COVID19-specific considerations
por: Nocera, Luigi, et al.
Publicado: (2022)

Comparison Between Urothelial and Non-Urothelial Urethral Cancer
por: Wenzel, Mike, et al.
Publicado: (2021)

Nonurological malignancies in children
por: Parida, Lalit
Publicado: (2014)

Comparison between 1973 and 2004/2016 World Health Organization grading in upper tract urothelial carcinoma treated with radical nephroureterectomy
por: Collà Ruvolo , Claudia, et al.
Publicado: (2021)

Radiation therapy after radical prostatectomy is associated with higher other-cause mortality
por: Würnschimmel, Christoph, et al.
Publicado: (2022)

Effect of Chemotherapy on Overall Survival in Contemporary Metastatic Prostate Cancer Patients
por: Hoeh, Benedikt, et al.
Publicado: (2021)

An external validation of the nocera nomogram: Predicting non-organ confined stage of ≥pT3 in cT1 clear cell renal cell carcinoma
por: Wenzel, Mike, et al.
Publicado: (2022)

Immunohistochemistry for Prostate Biopsy—Impact on Histological Prostate Cancer Diagnoses and Clinical Decision Making
por: Mandel, Philipp, et al.
Publicado: (2021)

Effect of prostatic apex shape (Lee types) and urethral sphincter length in preoperative MRI on very early continence rates after radical prostatectomy
por: Wenzel, Mike, et al.
Publicado: (2021)

Sex-related differences in non-urothelial variant histology, non-muscle invasive bladder cancer
por: Flammia, Rocco Simone, et al.
Publicado: (2022)

External Tertiary-Care-Hospital Validation of the Epidemiological SEER-Based Nomogram Predicting Downgrading in High-Risk Prostate Cancer Patients Treated with Radical Prostatectomy
por: Cano Garcia, Cristina, et al.
Publicado: (2023)

Incidence, Outcomes, and Prediction of Postoperative Urinary Retention After a Nonurologic Procedure
por: Abdul-Muhsin, Haidar M., et al.
Publicado: (2020)

Correlation of MRI-Lesion Targeted Biopsy vs. Systematic Biopsy Gleason Score with Final Pathological Gleason Score after Radical Prostatectomy
por: Wenzel, Mike, et al.
Publicado: (2021)

Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer
por: Hoeh, Benedikt, et al.
Publicado: (2022)

North American population-based validation of the National Comprehensive Cancer Network Practice Guideline Recommendations for locoregional lymph node and bone imaging in prostate cancer patients
por: Preisser, Felix, et al.
Publicado: (2018)

Correlation of Urine Loss after Catheter Removal and Early Continence in Men Undergoing Radical Prostatectomy
por: Hoeh, Benedikt, et al.
Publicado: (2021)

Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancer
por: Preisser, Felix, et al.
Publicado: (2021)

Differences in long-term continence rates between prostate cancer patients with extraprostatic vs. organ-confined disease undergoing robotic-assisted radical prostatectomy: An observational studys
por: Cano Garcia, Cristina, et al.
Publicado: (2023)

Association of Age With Risk of Adverse Pathological Findings at Radical Prostatectomy in Men With Gleason Score 6 Prostate Cancer
por: Kim, Daniel W., et al.
Publicado: (2020)

Survival of Testicular Pure Teratoma vs. Mixed Germ Cell Tumor Patients in Primary Tumor Specimens across All Stages
por: Cano Garcia, Cristina, et al.
Publicado: (2023)

Effect of Neoadjuvant Chemotherapy on Complications, in-Hospital Mortality, Length of Stay and Total Hospital Costs in Bladder Cancer Patients Undergoing Radical Cystectomy
por: Hoeh, Benedikt, et al.
Publicado: (2022)

Diabetes mellitus lowers the chance of short-term urinary continence recovery in prostate cancer patients undergoing radical prostatectomy
por: Philippi, Alexander, et al.
Publicado: (2022)

MRI as a screening tool for prostate cancer: current evidence and future challenges
por: Würnschimmel, Christoph, et al.
Publicado: (2022)

Survival after radical prostatectomy versus radiation therapy in clinical node‐positive prostate cancer
por: Chierigo, Francesco, et al.
Publicado: (2022)

Effect of Inferior Vena Cava Tumor Thrombus on Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated with Cytoreductive Nephrectomy
por: Hoeh, Benedikt, et al.
Publicado: (2022)

Anatomical Fundamentals and Current Surgical Knowledge of Prostate Anatomy Related to Functional and Oncological Outcomes for Robotic-Assisted Radical Prostatectomy
por: Hoeh, Benedikt, et al.
Publicado: (2022)

Grade and stage misclassification in intermediate unfavorable‐risk prostate cancer radiotherapy candidates
por: Sorce, Gabriele, et al.
Publicado: (2022)

Full functional-length urethral sphincter- and neurovascular bundle preservation improves long-term continence rates after robotic-assisted radical prostatectomy
por: Hoeh, Benedikt, et al.
Publicado: (2022)

Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patients
por: Hoeh, Benedikt, et al.
Publicado: (2021)

Differences in Cancer-Specific Mortality after Trimodal Therapy for T2N0M0 Bladder Cancer according to Histological Subtype
por: Barletta, Francesco, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9thl4qmc4ntl2mal4ccjnikiv7